BriaCell Therapeutics Corp. (BCTX)
Nasdaq: BCTX · Pharmaceutical Preparations · West Vancouver, BC · filing with the SEC since 2014
Filings
308 filings since 2017 beside 14 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Oct 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Dec 15, 2026
10-K
Annual report for the fiscal year ending Jul 31, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Oct 29, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Feb 12, 2026.
Filings a yearinsider forms included
1120755138386622
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 1 time in the last 36 months, the newest Nov 25, 2024.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Aug 23, 2024.SEC letters: 19 in the last 36 months, the newest Jan 8, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Jun 3, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
May 31, 2026
Jan 15, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Jan 13, 2026
Jul 16, 2025
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Jul 15, 2025
40 of 308 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.